Paper20004190
A comparative study of alpha-adrenergic receptor mediated Ca(2+) signals and contraction in intact human and mouse vascular smooth muscle.
Dai JM and 6 others. Eur J Pharmacol, 2010. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. A comparative study of alpha-adrenergic receptor mediated Ca(2+) signals and contraction in intact human and mouse vascular smooth muscle. Papers, record 20004190. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20004190
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A comparative study of alpha-adrenergic receptor mediated Ca(2+) signals and contraction in intact human and mouse vascular smooth muscle.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium Signaling | Major topic |
| Muscle, Smooth, Vascular | Major topic |
| Receptors, Adrenergic, alpha | Major topic |
| Vasoconstriction | Major topic |
| Abdomen | |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Animals | |
| Cell Membrane | |
| Female | |
| Humans | |
| In Vitro Techniques | |
| Male | |
| Mesenteric Arteries | |
| Mice | |
| Middle Aged | |
| Phenylephrine | |
| Sarcoplasmic Reticulum | |
| Vascular Diseases | |
| Young Adult |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Canadian Institutes of Health Research | Canada | PubMed |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42651821 | Neuro-Mechanical Regulation of Vascular Smooth Muscle Cell Behaviour Under Ageing-Associated Substrate Stiffness. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42651821 | PubMed |
| 37310356 | LRRC8A anion channels modulate vascular reactivity via association with myosin phosphatase rho interacting protein. | FASEB J | 2023 | https://conductscience.org/library/papers/37310356 | PubMed |
| 35055032 | Two-Dimensional Interfacial Exchange Diffusion Has the Potential to Augment Spatiotemporal Precision of Ca2+ Signaling. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35055032 | PubMed |
| 32918949 | Aging, calcium channel signaling and vascular tone. | Mech Ageing Dev | 2020 | https://conductscience.org/library/papers/32918949 | PubMed |
| 25626872 | Conditional knockout of smooth muscle sodium calcium exchanger type-1 lowers blood pressure and attenuates Angiotensin II-salt hypertension. | Physiol Rep | 2015 | https://conductscience.org/library/papers/25626872 | PubMed |
| 23408969 | Waves of calcium depletion in the sarcoplasmic reticulum of vascular smooth muscle cells: an inside view of spatiotemporal Ca2+ regulation. | PLoS One | 2013 | https://conductscience.org/library/papers/23408969 | PubMed |
| 22083879 | The role of cytoplasmic nanospaces in smooth muscle cell Ca2+ signalling. | Protoplasma | 2012 | https://conductscience.org/library/papers/22083879 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20004190
GET https://conductscience.org/api/papers/v1/20004190/authors